These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

890 related articles for article (PubMed ID: 26871000)

  • 21. Carnosine-LVFFARK-NH
    Zhang H; Dong X; Sun Y
    ACS Chem Neurosci; 2018 Nov; 9(11):2689-2700. PubMed ID: 30036471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple function fluorescein probe performs metal chelation, disaggregation, and modulation of aggregated Aβ and Aβ-Cu complex.
    Muthuraj B; Layek S; Balaji SN; Trivedi V; Iyer PK
    ACS Chem Neurosci; 2015 Nov; 6(11):1880-91. PubMed ID: 26332658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid-β peptide (1-42) aggregation induced by copper ions under acidic conditions.
    Bin Y; Li X; He Y; Chen S; Xiang J
    Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):570-7. PubMed ID: 23747389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylation of the imidazole side chains of the Alzheimer disease amyloid-beta peptide results in abolition of superoxide dismutase-like structures and inhibition of neurotoxicity.
    Tickler AK; Smith DG; Ciccotosto GD; Tew DJ; Curtain CC; Carrington D; Masters CL; Bush AI; Cherny RA; Cappai R; Wade JD; Barnham KJ
    J Biol Chem; 2005 Apr; 280(14):13355-63. PubMed ID: 15668252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The structures of the E22Δ mutant-type amyloid-β alloforms and the impact of E22Δ mutation on the structures of the wild-type amyloid-β alloforms.
    Coskuner O; Wise-Scira O; Perry G; Kitahara T
    ACS Chem Neurosci; 2013 Feb; 4(2):310-20. PubMed ID: 23421682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling the Cu+ binding in the 1-16 region of the amyloid-β peptide involved in Alzheimer's disease.
    Furlan S; Hureau C; Faller P; La Penna G
    J Phys Chem B; 2010 Nov; 114(46):15119-33. PubMed ID: 21038888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dimerization of Aβ40 inside dipalmitoylphosphatidylcholine bilayer and its effect on bilayer integrity: Atomistic simulation at three temperatures.
    Kargar F; Emadi S; Fazli H
    Proteins; 2020 Nov; 88(11):1540-1552. PubMed ID: 32557766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitration of amyloid-β peptide (1-42) as a protective mechanism for the amyloid-β peptide (1-42) against copper ion toxicity.
    Zhao J; Gao W; Yang Z; Li H; Gao Z
    J Inorg Biochem; 2019 Jan; 190():15-23. PubMed ID: 30342351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulating Conformation of Aβ-Peptide: An Effective Way to Prevent Protein-Misfolding Disease.
    Ma X; Hua J; Wang K; Zhang H; Zhang C; He Y; Guo Z; Wang X
    Inorg Chem; 2018 Nov; 57(21):13533-13543. PubMed ID: 30345755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Cu(II) on the aggregation of amyloid-β.
    Weibull MGM; Simonsen S; Oksbjerg CR; Tiwari MK; Hemmingsen L
    J Biol Inorg Chem; 2019 Dec; 24(8):1197-1215. PubMed ID: 31602542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling copper binding to the amyloid-β peptide at different pH: toward a molecular mechanism for Cu reduction.
    Furlan S; Hureau C; Faller P; La Penna G
    J Phys Chem B; 2012 Oct; 116(39):11899-910. PubMed ID: 22974015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid peptide Aβ40 inhibits aggregation of Aβ42: evidence from molecular dynamics simulations.
    Viet MH; Li MS
    J Chem Phys; 2012 Jun; 136(24):245105. PubMed ID: 22755606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NBD-BPEA regulates Zn
    Chen T; Zhang Y; Shang Y; Gu X; Zhu Y; Zhu L
    Food Chem Toxicol; 2018 Sep; 119():260-267. PubMed ID: 29596976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The nickel-chelator dimethylglyoxime inhibits human amyloid beta peptide in vitro aggregation.
    Benoit SL; Maier RJ
    Sci Rep; 2021 Mar; 11(1):6622. PubMed ID: 33758258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
    Xu L; Chen Y; Wang X
    Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The chelation targeting metal-Aβ40 aggregates may lead to formation of Aβ40 oligomers.
    Zhang Y; Chen LY; Yin WX; Yin J; Zhang SB; Liu CL
    Dalton Trans; 2011 May; 40(18):4830-3. PubMed ID: 21437337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aggregation of Alzheimer's amyloid β-peptide in biological membranes: a molecular dynamics study.
    Lemkul JA; Bevan DR
    Biochemistry; 2013 Jul; 52(29):4971-80. PubMed ID: 23855340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simulations of monomeric amyloid β-peptide (1-40) with varying solution conditions and oxidation state of Met35: implications for aggregation.
    Brown AM; Lemkul JA; Schaum N; Bevan DR
    Arch Biochem Biophys; 2014 Mar; 545():44-52. PubMed ID: 24418316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of nonapeptide LVFFARKHH: A bifunctional agent against Cu
    Zhang H; Zhang C; Dong XY; Zheng J; Sun Y
    J Mol Recognit; 2018 Jun; 31(6):e2697. PubMed ID: 29318655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.